137 results
Page 4 of 7
8-K
EX-99.2
uqb27r cu9
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
DRS
EX-10.53
thsluxkq
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.54
siedjbmlppdag
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.58
pleap
23 Jun 20
Draft registration statement
12:00am
DRS
EX-10.55
hcmkc
23 Jun 20
Draft registration statement
12:00am
8-K
EX-99.1
9fbcr0iat1f6z5 lk
19 Jun 20
Patent License Agreement
5:26pm
8-K
EX-99.1
veb388tb 2xpdrx9d
29 May 20
Vir Biotechnology and Biogen Execute Agreement to ManufactureSARS-CoV-2 Antibodies for PotentialCOVID-19 Treatment
4:06pm
D
ljxlqv 1oh
8 May 20
$32.44M in equity, sold $32.44M, 1 investor
4:04pm
D
qxn2e
8 May 20
$250M in equity, sold $250M, 1 investor
4:01pm
DEF 14A
r0x75wtzx
6 Apr 20
Definitive proxy
4:52pm
10-K
2fgbpf muqeh
26 Mar 20
Annual report
4:08pm
10-Q
m940kx3
19 Nov 19
Quarterly report
4:06pm
8-K
EX-3.2
szkw mhfcvc5
16 Oct 19
Departure of Directors or Certain Officers
4:01pm
S-8
EX-4.11
ovekth4l79 k2c6
15 Oct 19
Registration of securities for employees
4:47pm
S-8
EX-4.8
e7cv374y 8977h
15 Oct 19
Registration of securities for employees
4:47pm
424B4
i4s37n0hm90ld
11 Oct 19
Prospectus supplement with pricing info
5:31pm